New Jersey S2283 establishes a Psilocybin Behavioral Health Access and Therapy Pilot Program, appropriating $6 million.
New Jersey S2283 establishes a Psilocybin Behavioral Health Access and Therapy Pilot Program, appropriating $6 million. The bill decriminalizes and expunges past convictions for certain psilocybin-related conduct. It authorizes the production and use of psilocybin for behavioral health care purposes. The bill mandates the Department of Health to regulate psilocybin product manufacturers, service centers, and facilitators. It sets standards for licensing, product labeling, and client safety.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
Analyze for Free
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.